DexCom (DXCM) PT Raised to $450 at Piper Sandler; Non-Intensive Market Worth Price of Admission
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien raised the price target on DexCom (NASDAQ: DXCM) to $450.00 (from $375.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
